Tag: Hepatitis
FDA Approves Mavyret for Hepatitis C
Combo drug is first approved therapy for hepatitis C to require as few as eight weeks of treatment
More Progress Needed for Hep C Elimination in Country of Georgia
Overall, 84.1 percent of those tested for HCV RNA after treatment had no detectable virus in their blood
Noninvasive Oral Fluid-Based Immunoassay IDs Hepatitis E
Assay has high sensitivity and specificity for identifying past and recent HEV infection
EHR-Based Prompt Ups Hepatitis C Screening for Baby Boomers
Prompt improves hepatitis C virus screening rates, and all patients are referred to specialty care
Subcirrhotic Liver Stiffness Cuts HCC Risk in Hepatitis B
Achievement of subcirrhotic range of liver stiffness with antiviral therapy reduces HCC risk
Improved Glycemic Control With Eradication of Hepatitis C
Improved glycemic control, reduced antidiabetic medication use with sustained virologic response
HCC Drops Beyond Five Years of Entecavir/Tenofovir Tx for Hep B
Older age, lower platelets at baseline and year five, liver stiffness ≥12 kPa linked to HCC development
High HCV Cure Rates in HIV Coinfection Cases at Urban Clinic
Sustained virologic response rate of 97 percent, with no variation by race in predominantly black cohort
Three-Drug Combo Pill Nearly 100 Percent Effective in Curing Hep C
Pill (sofosbuvir, velpatasvir, voxilaprevir) is for patients who have failed with direct-acting antivirals
CDC: Hep C Infections Among Pregnant Women Increasing
Rural counties seem hardest hit and rates mirror opioid epidemic
